IL120202A - Container with freeze-dried vaccine components - Google Patents

Container with freeze-dried vaccine components

Info

Publication number
IL120202A
IL120202A IL12020297A IL12020297A IL120202A IL 120202 A IL120202 A IL 120202A IL 12020297 A IL12020297 A IL 12020297A IL 12020297 A IL12020297 A IL 12020297A IL 120202 A IL120202 A IL 120202A
Authority
IL
Israel
Prior art keywords
container
freeze
vaccine
vaccine components
dried vaccine
Prior art date
Application number
IL12020297A
Other languages
English (en)
Other versions
IL120202A0 (en
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL120202A0 publication Critical patent/IL120202A0/xx
Publication of IL120202A publication Critical patent/IL120202A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Drying Of Solid Materials (AREA)
IL12020297A 1996-03-07 1997-02-11 Container with freeze-dried vaccine components IL120202A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96200621 1996-03-07

Publications (2)

Publication Number Publication Date
IL120202A0 IL120202A0 (en) 1997-06-10
IL120202A true IL120202A (en) 2001-03-19

Family

ID=8223754

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12020297A IL120202A (en) 1996-03-07 1997-02-11 Container with freeze-dried vaccine components

Country Status (19)

Country Link
US (2) US5897852A (de)
EP (1) EP0799613B1 (de)
JP (1) JP4293643B2 (de)
KR (1) KR100458370B1 (de)
CN (1) CN1133423C (de)
AT (1) ATE202925T1 (de)
AU (1) AU704629B2 (de)
CA (1) CA2198195C (de)
DE (1) DE69705569T2 (de)
DK (1) DK0799613T3 (de)
EG (1) EG23992A (de)
ES (1) ES2161412T3 (de)
GR (1) GR3036725T3 (de)
HU (1) HU220532B1 (de)
IL (1) IL120202A (de)
NZ (1) NZ314267A (de)
PT (1) PT799613E (de)
SA (1) SA97170715B1 (de)
ZA (1) ZA971734B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
AU779403B2 (en) 1999-08-24 2005-01-20 Teva Pharmaceutical Industries Ltd. A vaccine composition and method of using the same
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
US7863012B2 (en) * 2004-02-17 2011-01-04 Veridex, Llc Analysis of circulating tumor cells, fragments, and debris
AUPR750501A0 (en) * 2001-09-05 2001-09-27 Gauci, Mark Products comprising quantum of bioparticles and method for production thereof
US6780581B2 (en) 2001-09-12 2004-08-24 Btf Pty Ltd Products comprising quantum of bioparticles and method for production thereof
WO2013034682A1 (en) 2011-09-08 2013-03-14 Umc Utrecht Holding B.V. Vaccine based on staphylococcal superantigen- line 3 protein (ssl3)
EP2272502A1 (de) * 2003-12-19 2011-01-12 Alk-Abelló A/S Kyrogranulate einer Flüssigzusammensetzung für ein Allergenprodukt
US20050181353A1 (en) * 2004-02-17 2005-08-18 Rao Galla C. Stabilization of cells and biological specimens for analysis
TWI436789B (zh) * 2008-01-21 2014-05-11 Intervet Int Bv 含有藥學化合物的顆粒之冷凍乾燥方法及含有此顆粒的藥學包
TWI444384B (zh) * 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
CN105944095B (zh) 2008-03-05 2021-04-02 赛诺菲巴斯德有限公司 一种使含佐剂的疫苗组合物稳定的方法
EP2143440A1 (de) 2008-07-09 2010-01-13 Sanofi Pasteur Stabilisierungssubstanz und Impfzusammensetzung, die ein oder mehrere abgeschwächte lebende Flaviviridae enthält
TW201043267A (en) 2009-03-19 2010-12-16 Intervet Int Bv In situ constituting a vaccine for administration to a predetermined herd of animals
WO2012089748A1 (en) 2010-12-29 2012-07-05 Intervet International B.V. Canine babesiosis vaccine antigen
JP2014533240A (ja) 2011-10-31 2014-12-11 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． 生物材料の凍結乾燥球形ペレットを調製する方法
JP6855469B2 (ja) * 2015-10-16 2021-04-07 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． 消化器標的療法のための処方物を調製するための工程
NL2018155B1 (en) 2017-01-11 2018-07-25 Intervet Int Bv Oral vaccine against ruminant respiratory disease
CN113862332A (zh) * 2021-09-17 2021-12-31 浙江大学 琼脂糖在制备生物大分子冻干保护剂中的应用
CN114159555A (zh) * 2021-12-08 2022-03-11 江西赛基生物技术有限公司 抗原蛋白冻干小球及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655838A (en) * 1969-03-20 1972-04-11 Organon Method of pelletizing analytical or immunological reagents
US3932943A (en) * 1970-08-14 1976-01-20 E. I. Du Pont De Nemours And Company Method of preparation of lyophilized biological products
DE2243014C2 (de) * 1971-09-03 1986-05-28 E.I. Du Pont De Nemours And Co., Wilmington, Del. Verfahren zur Herstellung eines homogenen, gefriergetrockneten Serum- oder Plasmaproduktes
US3857423A (en) * 1971-12-27 1974-12-31 W Ronca Topical medicament kit with interlocking components
US3893280A (en) * 1972-06-21 1975-07-08 Burns Biotec Lab Inc Transfer packaging for biologicals
US4351158A (en) * 1980-01-22 1982-09-28 American Home Products Corporation Method of producing multicomponent lyophilized product
US4295280A (en) * 1980-03-17 1981-10-20 American Home Products Corporation Method of obtaining a lyophilized product
US4981685A (en) * 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US4712310A (en) * 1986-09-15 1987-12-15 E. I. Du Pont De Nemours And Company Co-spray technique
IL86180A (en) 1987-05-04 1992-08-18 Merck & Co Inc Stable lyophilized live herpes virus vaccine and such a vaccine combined with other virus vaccines
AT390192B (de) * 1988-08-29 1990-03-26 Immuno Ag Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen
JPH07116022B2 (ja) * 1989-04-18 1995-12-13 三共株式会社 凍結乾燥製剤の製法
ATE99546T1 (de) * 1989-05-01 1994-01-15 Alkermes Inc Verfahren zur herstellung von kleinen partikeln von biologisch aktiven molekuelen.
US5270057A (en) * 1990-03-20 1993-12-14 Akzo N.V. Stabilized gonadotropin containing preparations
IE64738B1 (en) 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
AU650045B2 (en) * 1990-09-12 1994-06-09 Lifecell Corporation Method and apparatus for cryopreparation dry stabilization and rehydration of biological suspensions
EP0695171B1 (de) * 1993-04-28 1996-12-18 Akzo Nobel N.V. Gonadotropin enthaltende gefriergetrocknete troepfen
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components

Also Published As

Publication number Publication date
CA2198195A1 (en) 1997-09-07
CA2198195C (en) 2005-10-25
HUP9700556A2 (en) 1997-12-29
HU220532B1 (hu) 2002-03-28
ATE202925T1 (de) 2001-07-15
HUP9700556A3 (en) 2000-04-28
DK0799613T3 (da) 2001-10-22
MX9701726A (es) 1998-03-31
JP4293643B2 (ja) 2009-07-08
US5897852A (en) 1999-04-27
KR970064584A (ko) 1997-10-13
AU704629B2 (en) 1999-04-29
DE69705569D1 (de) 2001-08-16
CN1163102A (zh) 1997-10-29
ES2161412T3 (es) 2001-12-01
PT799613E (pt) 2001-12-28
EP0799613A1 (de) 1997-10-08
EP0799613B1 (de) 2001-07-11
DE69705569T2 (de) 2002-05-16
EG23992A (en) 2008-03-09
ZA971734B (en) 1997-09-09
IL120202A0 (en) 1997-06-10
US6106836A (en) 2000-08-22
GR3036725T3 (en) 2001-12-31
NZ314267A (en) 1998-01-26
KR100458370B1 (ko) 2005-07-07
HU9700556D0 (en) 1997-04-28
JPH1024090A (ja) 1998-01-27
SA97170715B1 (ar) 2006-10-11
CN1133423C (zh) 2004-01-07
AU1514997A (en) 1997-09-11

Similar Documents

Publication Publication Date Title
EG23992A (en) Container with freeze-dried vaccine components
AP9400629A0 (en) Vaccine compositions
EP0305073A3 (en) Curable organosiloxane compositions
MY113428A (en) Hepatitis b vaccine
PH31297A (en) Antiperspirant aerosol composition with high solids content.
EP0610629A3 (de) Hartbäre Organopolysiloxanzusammensetzungen.
EP0658364A3 (de) Zeolithzusammensetzungen für Gastrennungen.
EP0623310A3 (de) Faltbare Verpackung für chirurgische Produkte.
WO2001040177A3 (en) Esters of vitamin d3 and uses thereof
AU3025795A (en) Compositions which are suitable for employment as antidotes to blood anticoagulants, and their use
EP0247326A3 (en) Resin compositions, laminates and block copolymers as components thereof
PH31219A (en) Stable lyophilized thiotepa composition.
PH30815A (en) Composition.
AU5639390A (en) Gangliotetraosylceramide as an adsorbent for enteric viral pathogens
AU7008494A (en) Methods and compositions for (salmonella)-based vaccines
EP0635482A3 (de) Verfahren zur Herstellung von mehrfach fluorierten Nitrobenzolen.
AP2000001746A0 (en) Anti- first-pass effect compounds.
EP0634335A3 (de) Fuss zum Ergänzen eines Kartons zu einer Boxpalette.
EP0316639A3 (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
EP0402160A3 (de) Amin-Alkylboran-Derivate und Verfahren
DE69023630D1 (de) Anordnung zur korrektur des vertikalen kommafehlers.
EP0811646A3 (de) Hitzehärtbare Zusammensetzungen auf Basis von zyklischen Isocyanataddukten
EP0635486A3 (de) Verfahren zur Herstellung von Fluorbenzonitrilen.
WO2000023351A3 (de) Verpackung fuer die bestandteile eines zerlegten schaltschrankes
IL100221A0 (en) Compositions based on polyphosphazene,particularly for floor covering

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired